New Business Partnership For Guiding Microchimerism to Transplant Diagnostics with DigitalTRACE™

07/04/2022

Omixon is pleased to announce that we have been entered a new strategic partnership of JETA Molecular BV., based in Utrecht, The Netherlands, effective as of April 2022. This partnership will combine Omixon’s expertise as an international provider of disruptive transplant diagnostics solutions with JETA Molecular latest technological solutions aimed...

Interview with Gergely Tölgyesi, Molecular Biologist at Omixon

30/09/2019

The following interview is part of the Omixon interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers at Omixon. This time Gergely Tölgyesi, Technical Lead of Assay R&D answers questions related to his professional background, history of joining the Omixon team and shares secrets about...